In 2023, the pharmaceutical group Menarini celebrated the significant milestone of thirty-one years of operations in Poland. A story that began in 1992, just three years after the fall of the Berlin Wall, when Cavaliere Alberto Sergio Aleotti, leveraging his entrepreneurial vision, acquired the German company Berlin-Chemie. This strategic move not only opened the doors to the German market but also marked the beginning of expansion into Eastern Europe. Today, Berlin-Chemie distributes its pharmaceutical products in over 90 nations and has a consolidated presence, with branches in more than 30 countries.

Over the course of thirty years, Menarini’s Polish division has experienced remarkable growth: from its beginnings when business revolved around a small office in the center of Warsaw, the company has managed to consolidate its position in the market. Today, it boasts 450 employees and a portfolio of over 40 products. In this way, Menarini Poland has earned a place among the top ten pharmaceutical companies in Poland, with a turnover of over 200 million euros.

One of the pillars upon which Berlin-Chemie Menarini Poland’s success is built is its extensive assortment of both over-the-counter and prescription drugs. These products are highly valued by both consumers and healthcare professionals, a testament to the company’s commitment to research and development of cutting-edge therapeutic solutions.

“Looking back and seeing how far we’ve come is truly a great satisfaction,” said Joanna Kawecka, General Manager of the Polish division. “Berlin-Chemie Menarini Poland has always sought to be a point of reference on health issues, and managed to become one over the years. Our mission is to create a scientific culture in the Eastern European area, while still maintaining professionalism and active involvement of people. I wish for our entire company to continue to grow with the same positive energy that has brought us this far.“

Berlin-Chemie Menarini Poland Today

Berlin-Chemie Menarini Poland operates in several crucial therapeutic areas, including cardiology, gastroenterology, thyroid diseases, diabetology, allergology, pulmonology, as well as painkillers, anti-inflammatory drugs, and antibiotic therapies. The company is renowned for the quality of its drugs, which improve patients’ comfort on a daily basis.

Furthermore, the Polish division is actively engaged in supporting the medical community through  educational events and scientific congresses. These initiatives not only reinforce Menarini’s position as a leader in the sector but also contribute to the advancement of medical knowledge in the region.

Recently, Berlin-Chemie Menarini Poland was recognized as the “Partner of Polish Cardiology” and received the “Golden Blood Pressure Monitor Award” from the hypertension community. Berlin-Chemie Menarini Poland was also awarded the title of “Friend” by societies of endocrinology, rheumatology, thyroidology, and allergology.

The success of the Polish division is also due to a corporate culture that makes the well-being of employees its strength, promoting values of mutual respect, collaboration, and integrity: values that foster a productive work environment, as confirmed by a recent internal survey that expressed a very high overall satisfaction among workers, and are also reflected in the high quality of the products and services offered by the company.

Looking to the future, Berlin-Chemie Menarini Poland is determined to maintain its growth trajectory. The company continues to focus on expanding its product portfolio and deepening its relationships with the medical community. With a history of passion, dedication, and constant commitment to innovation, Berlin-Chemie Menarini Poland aims to remain at the forefront of the pharmaceutical industry, advancing its mission to improve the health and quality of life of patients and continuing to show how corporate vision and human values can go hand in hand towards success.